Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA107934
Max Phase: Preclinical
Molecular Formula: C23H23FN2O4Si
Molecular Weight: 438.53
Molecule Type: Small molecule
Associated Items:
ID: ALA107934
Max Phase: Preclinical
Molecular Formula: C23H23FN2O4Si
Molecular Weight: 438.53
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cccc(F)c1c2[Si](C)(C)C
Standard InChI: InChI=1S/C23H23FN2O4Si/c1-5-23(29)14-9-17-19-12(10-26(17)21(27)13(14)11-30-22(23)28)20(31(2,3)4)18-15(24)7-6-8-16(18)25-19/h6-9,29H,5,10-11H2,1-4H3/t23-/m0/s1
Standard InChI Key: KEQQOYYTNHAFFN-QHCPKHFHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 438.53 | Molecular Weight (Monoisotopic): 438.1411 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Josien H, Bom D, Curran DP, Zheng Y, Chou T. (1997) 7-Silylcamptothecins (silatecans): A new family of camptothecin antitumor agents, 7 (24): [10.1016/S0960-894X(97)10181-0] |
Source(1):